What is Arcus Biosciences's stock issuance proceeds?

Arcus Biosciences (RCUS) reported stock issuance proceeds of $0 in Q1 2026.

How has Arcus Biosciences's stock issuance proceeds changed year-over-year?

Arcus Biosciences's stock issuance proceeds decreased by 100.0% year-over-year, from $142M to $0.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Arcus Biosciences RCUS Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Merck & Co.MRK

$157M+726%

Regeneron PharmaceuticalsREGN

$163.1M+169%

IDEAYA Biosciences, Inc.IDYA

$1.19M+4.9%

IncyteINCY

$97.93M+2,923%

Erasca, Inc.ERAS

$258.75M+783,991%

ImmunityBio, Inc.IBRX

$971K+341%

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.54B+226%

Enterprise value$3.46B+275%

P/S15×+7.3×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's stock issuance proceeds?: Arcus Biosciences (RCUS) reported stock issuance proceeds of $0 in Q1 2026.
How has Arcus Biosciences's stock issuance proceeds changed year-over-year?: Arcus Biosciences's stock issuance proceeds decreased by 100.0% year-over-year, from $142M to $0.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.